Stifel raises Ionis Pharmaceuticals stock price target to $67 from $43
PositiveFinancial Markets

Stifel has raised its price target for Ionis Pharmaceuticals from $43 to $67, reflecting a positive outlook on the company's future performance. This adjustment indicates confidence in Ionis's growth potential and could attract more investors, highlighting the company's advancements in drug development and market position.
— Curated by the World Pulse Now AI Editorial System